1. Home
  2. GSL vs NUWE Comparison

GSL vs NUWE Comparison

Compare GSL & NUWE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSL
  • NUWE
  • Stock Information
  • Founded
  • GSL 2007
  • NUWE 1999
  • Country
  • GSL Greece
  • NUWE United States
  • Employees
  • GSL N/A
  • NUWE N/A
  • Industry
  • GSL Marine Transportation
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GSL Consumer Discretionary
  • NUWE Health Care
  • Exchange
  • GSL Nasdaq
  • NUWE Nasdaq
  • Market Cap
  • GSL N/A
  • NUWE 3.9M
  • IPO Year
  • GSL 2006
  • NUWE N/A
  • Fundamental
  • Price
  • GSL $21.13
  • NUWE $0.93
  • Analyst Decision
  • GSL Strong Buy
  • NUWE Strong Buy
  • Analyst Count
  • GSL 1
  • NUWE 1
  • Target Price
  • GSL $29.00
  • NUWE $17.00
  • AVG Volume (30 Days)
  • GSL 474.3K
  • NUWE 61.5K
  • Earning Date
  • GSL 05-15-2025
  • NUWE 05-06-2025
  • Dividend Yield
  • GSL 8.52%
  • NUWE N/A
  • EPS Growth
  • GSL 17.78
  • NUWE N/A
  • EPS
  • GSL 9.67
  • NUWE N/A
  • Revenue
  • GSL $705,529,000.00
  • NUWE $8,740,000.00
  • Revenue This Year
  • GSL $1.84
  • NUWE $22.96
  • Revenue Next Year
  • GSL N/A
  • NUWE $29.97
  • P/E Ratio
  • GSL $2.15
  • NUWE N/A
  • Revenue Growth
  • GSL 5.82
  • NUWE N/A
  • 52 Week Low
  • GSL $17.73
  • NUWE $0.75
  • 52 Week High
  • GSL $30.32
  • NUWE $14.00
  • Technical
  • Relative Strength Index (RSI)
  • GSL 50.74
  • NUWE 47.12
  • Support Level
  • GSL $19.77
  • NUWE $0.86
  • Resistance Level
  • GSL $20.62
  • NUWE $0.95
  • Average True Range (ATR)
  • GSL 0.89
  • NUWE 0.08
  • MACD
  • GSL 0.15
  • NUWE 0.01
  • Stochastic Oscillator
  • GSL 99.42
  • NUWE 76.71

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

Share on Social Networks: